Medicare Enrolled
Dr. Rohan Faria, M.D.
Hematology & Oncology · Coral Springs, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Faria from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faria?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Faria
Dr. Rohan Faria is a hematology & oncology specialist in Coral Springs, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Faria performed 71,513 Medicare services across 3,167 unique beneficiaries.
Between the years covered by Open Payments, Dr. Faria received a total of $3,652 from 33 pharmaceutical and/or device companies across 191 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Faria is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in FL
$3,652 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 73674 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗71,513
Medicare services
Top 11% in FL for hematology & oncology
3,167
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,576 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
33,841 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 4,912 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 4,680 | $18 | $54 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,485 | $0 | $0 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
4,380 | $6 | $19 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
4,080 | $6 | $21 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,456 | $7 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,404 | $8 | $19 |
| Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 2,040 | $2 | $7 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,430 | $1 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
597 | $68 | $229 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
574 | $101 | $333 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
566 | $11 | $35 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
541 | $12 | $39 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
539 | $22 | $30 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
479 | $19 | $47 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
478 | $96 | $324 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
465 | $13 | $78 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
328 | $2 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
326 | $51 | $161 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
223 | $7 | $35 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 192 | $20 | $60 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
183 | $50 | $66 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
180 | $21 | $72 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
176 | $1 | $3 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
133 | $1 | $4 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
92 | $15 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
81 | $128 | $173 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
77 | $14 | $42 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
75 | $16 | $20 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
72 | $40 | $141 |
| PSA test (prostate cancer screening) | 69 | $18 | $46 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
66 | $27 | $36 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
66 | $97 | $304 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
64 | $14 | $88 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
61 | $16 | $21 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
50 | $18 | $27 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $142 | $442 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $145 | $455 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.5% high complexity
87.0% medium
10.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,652
Total received (2018-2024)
Avg $522/year across 7 years
Bottom 47% in FL for hematology & oncology
33
Companies
191
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,384 (92.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$269 (7.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$127
2023
$674
2022
$762
2021
$368
2020
$493
2019
$729
2018
$500
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,807
Foundation Medicine, Inc.
$237
PFIZER INC.
$188
Astellas Pharma US Inc
$157
Novartis Pharmaceuticals Corporation
$137
E.R. Squibb & Sons, L.L.C.
$121
Bayer HealthCare Pharmaceuticals Inc.
$79
Deciphera Pharmaceuticals Inc.
$77
AbbVie, Inc.
$72
SERVIER PHARMACEUTICALS LLC
$70
ABBVIE INC.
$64
Aurobindo Pharma USA, Inc.
$57
Eisai Inc.
$49
EISAI INC.
$48
Adaptive Biotechnologies Corporation
$46
ARRAY BIOPHARMA INC
$44
Pharmacyclics LLC, An AbbVie Company
$41
Incyte Corporation
$39
Janssen Pharmaceuticals, Inc
$34
Daiichi Sankyo Inc.
$30
Teva Pharmaceuticals USA, Inc.
$30
Coherus Biosciences Inc.
$28
Rigel Pharmaceuticals, Inc.
$26
Amgen Inc.
$26
Octapharma USA, Inc.
$25
Exelixis Inc.
$22
AstraZeneca Pharmaceuticals LP
$19
TOLMAR Pharmaceuticals, Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$16
GlaxoSmithKline, LLC.
$15
Gilead Sciences, Inc.
$12
Alexion Pharmaceuticals, Inc.
$11
Clovis Oncology, Inc.
$8
Top 3 companies account for 61.1% of total payments
Associated products mentioned in payments ›
Aliqopa · BENDEKA · BRAFTOVI · Beleodaq · CABOMETYX · CALQUENCE · DARZALEX · ELIGARD · ELIQUIS · ERLEADA · Enhertu · Erleada · FOUNDATIONONE · Folotyn · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · INJECTAFER · Imbruvica · JAKAFI · KISQALI · LUTATHERA · Lenvima · MEKINIST · Nplate · Nubeqa · OCTAPLAS · OPDIVO · PROMACTA · QINLOCK · Rezlidhia · Rubraca · SOLIRIS · Stivarga · TECVAYLI · Tibsovo · Udenyca · VENCLEXTA · Venclexta · WILATE · XARELTO · XTANDI · ZEJULA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
115
Per 100K population
5.9
County median income
$74,534
Nearest hospital
BROWARD HEALTH CORAL SPRINGS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Faria is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Faria experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Faria performed 33,841 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Faria receive payments from pharmaceutical companies?
Yes. Dr. Faria received a total of $3,652 from 33 companies across 191 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faria's costs compare to other hematology & oncology specialists in Coral Springs?
Dr. Faria's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faria) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Coral Springs
Browse hematology & oncology specialists in Coral Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Foundation Medicine, Inc. Payments to Doctors
See all physicians who received payments from Foundation Medicine, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology